“…Decrease in HRV has been found to predict coronary heart disease morbidity and mortality in apparently healthy populations and in patients after an acute coronary event (Akselrod et al 1981). There has been a large scale growth in HRV research in disease states such as diabetic neuropathy (Bernardi et al 1992), cardiac transplantation (Sands et al 1989), myocardial dysfunction (Casolo et al 1989), tetraplegia (Inoue et al 1990), preschool children with short nocturnal sleep (Sampei et al 2006), primary nocturnal enuresis (Dundaroz et al 2001;Unalacak et al 2004), allergic rhinitis (Yokusoglu et al 2007), fetal type Minamata disease (Oka et al 2003), administration of beta blockers (Adamson et al 1994), cardiac resynchronization therapy (Akyol et al 2006), antiarrhytmics (Zuanetti et al 1991) and scopolamine (De Ferrari et al 1993). However, the impact of HRV on clinical decisions is limited.…”